How do you use Relyvrio in a sentence? See 2 example sentences showing how this word appears in different contexts.
Relyvrio in a sentence
Context around Relyvrio
- Average sentence length in these examples: 24 words
- Position in the sentence: 0 start, 1 middle, 1 end
- Sentence types: 2 statements, 0 questions, 0 exclamations
Corpus analysis for Relyvrio
- In this selection, "relyvrio" usually appears in the middle of the sentence. The average example has 24 words, and this corpus slice is mostly made up of statements.
- Around the word, product and withdraw stand out and add context to how "relyvrio" is used.
- Recognizable usage signals include flagship product relyvrio and would withdraw relyvrio from the. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "relyvrio" sits close to words such as aabc, aacr and aacsb, which helps place it inside the broader word index.
Example types with relyvrio
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Amylyx Pharmaceuticals, a biotech firm focusing on neurodegenerative disorders, has seen impressive Q1 2023 financial performance despite clinical uncertainties around its flagship product, Relyvrio. (24 words)
During the advisory committee preceding the FDA decision, Klee said Amylyx would withdraw Relyvrio from the market if it failed the larger clinical trial. (24 words)
Amylyx Pharmaceuticals, a biotech firm focusing on neurodegenerative disorders, has seen impressive Q1 2023 financial performance despite clinical uncertainties around its flagship product, Relyvrio. (24 words)
During the advisory committee preceding the FDA decision, Klee said Amylyx would withdraw Relyvrio from the market if it failed the larger clinical trial. (24 words)
Example sentences (2)
Amylyx Pharmaceuticals, a biotech firm focusing on neurodegenerative disorders, has seen impressive Q1 2023 financial performance despite clinical uncertainties around its flagship product, Relyvrio.
During the advisory committee preceding the FDA decision, Klee said Amylyx would withdraw Relyvrio from the market if it failed the larger clinical trial.